Cargando…
Intravitreal bevacizumab role in the treatment of macular edema secondary to retinal vasoproliferative tumor in a patient with neurofibromatosis type 1
Objective: To report a case of neurofibromatosis-1 (NF-1) with retinal vasoproliferative tumor (RVPT) and macular edema and exudation that was successfully treated with intravitreal bevacizumab (IVB). Method: A retrospective case report of patient with neurofibromatosis, retinal vasoproliferative tu...
Autores principales: | Nourinia, Ramin, Motevasseli, Tahmineh, Tofighi, Zahra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
German Medical Science GMS Publishing House
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039346/ https://www.ncbi.nlm.nih.gov/pubmed/27703870 http://dx.doi.org/10.3205/oc000045 |
Ejemplares similares
-
Macular Hole Formation in Eye After Cryotherapy and Intravitreal Bevacizumab Treatment for Vasoproliferative Tumor
por: Sato, Atsuko, et al.
Publicado: (2020) -
Combined intravitreal injection of bevacizumab and a ROCK inhibitor (fasudil) for refractory macular edema secondary to retinal vein occlusion: a pilot study
por: Fekri, Sahba, et al.
Publicado: (2022) -
Retinal vasoproliferative tumor regression after intravitreal aflibercept
por: Chu, Ting-Wen, et al.
Publicado: (2022) -
Intravitreal Fasudil Combined with Bevacizumab for Treatment of Refractory Diabetic Macular Edema; a Pilot Study
por: Nourinia, Ramin, et al.
Publicado: (2013) -
Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion
por: Gutiérrez, Juan Carlos Mesa, et al.
Publicado: (2008)